famotidine has been researched along with Liver Dysfunction in 3 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute effects of histamine H2 receptor antagonist, famotidine, on hepatic hemodynamics were studied in six normal volunteers and eight patients with chronic liver disease, and its chronic effects on peptic ulcer, portal hemodynamics, and hepatic function were studied in 20 patients with chronic liver disease and peptic ulcer (16 with gastric ulcer, four with duodenal ulcer)." | 7.67 | Effect of famotidine on hepatic hemodynamics and peptic ulcer. ( Goto, N; Nomura, F; Ohnishi, K; Ohtsuki, T; Okuda, K; Saito, M; Suzuki, N; Takashi, M, 1987) |
| "Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment." | 5.28 | Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990) |
| "The acute effects of histamine H2 receptor antagonist, famotidine, on hepatic hemodynamics were studied in six normal volunteers and eight patients with chronic liver disease, and its chronic effects on peptic ulcer, portal hemodynamics, and hepatic function were studied in 20 patients with chronic liver disease and peptic ulcer (16 with gastric ulcer, four with duodenal ulcer)." | 3.67 | Effect of famotidine on hepatic hemodynamics and peptic ulcer. ( Goto, N; Nomura, F; Ohnishi, K; Ohtsuki, T; Okuda, K; Saito, M; Suzuki, N; Takashi, M, 1987) |
| "Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment." | 1.28 | Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnishi, K | 2 |
| Saito, M | 1 |
| Nomura, F | 1 |
| Okuda, K | 1 |
| Suzuki, N | 1 |
| Ohtsuki, T | 1 |
| Goto, N | 1 |
| Takashi, M | 1 |
| Murase, T | 1 |
| Hazama, H | 1 |
| Okuno, H | 1 |
| Shiozaki, Y | 1 |
| Sameshima, Y | 1 |
3 other studies available for famotidine and Liver Dysfunction
| Article | Year |
|---|---|
Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
Topics: Adult; Chronic Disease; Famotidine; Female; Hepatitis; Humans; Liver Circulation; Liver Cirrhosis; L | 1990 |
Effect of famotidine on hepatic hemodynamics and peptic ulcer.
Topics: Adult; Chronic Disease; Dye Dilution Technique; Famotidine; Female; Hemodynamics; Histamine H2 Antag | 1987 |
Effect of H2-receptor antagonists on acetaminophen-induced hepatic injury.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cimetidine; Famotidine; Glutathione; | 1986 |